Avian erythroleukemia: a model for corepressor function in cancer

Area of Science:

• Molecular Biology
• Epigenetics
• Cancer Biology

Background:

• Histone acetylation status, controlled by protein complexes, is crucial for eukaryotic development and differentiation.
• Aberrant gene transcription due to imbalanced histone acetylation/deacetylation can lead to cancer.
• Oncoproteins from chromosomal translocations in acute promyelocytic leukemia (APL) and avian erythroleukemia (AEL) deregulate transcription by altering chromatin structure.

Purpose of the Study:

• To investigate the role of transcriptional regulation via chromatin modification in eukaryotic development and differentiation.
• To understand how oncogenic nuclear hormone receptors contribute to aberrant gene transcription and cancer.
• To explore therapeutic strategies for APL and AEL by targeting chromatin modification.

Main Methods:

• Analysis of histone acetylation and deacetylation mechanisms.
• Study of DNA-bound repressors and activators in recruiting histone modifying complexes.
• Investigation of oncogenic nuclear hormone receptors (RARalpha, TRalpha) and their role in gene repression.
• Examination of corepressor involvement in v-ErbA-mediated gene repression.

Main Results:

• Histone deacetylases and acetyltransferases are recruited by DNA-bound factors, influencing chromatin structure.
• Oncogenic receptors in APL and AEL constitutively repress critical genes for hematopoietic cell differentiation.
• v-ErbA, an oncogenic TRalpha, represses target genes like carbonic anhydrase II (CAII) through corepressor recruitment.

Conclusions:

• Chromatin modification is a key regulatory mechanism in development and differentiation.
• Therapeutic strategies targeting histone deacetylase or methylation inhibition can reactivate repressed genes.
• These chromatin-modifying agents offer promising new treatments for acute myeloid leukemia.